These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9043561)

  • 41. Impact of a pharmacy resident on hospital length of stay and drug-related costs.
    Terceros Y; Chahine-Chakhtoura C; Malinowski JE; Rickley WF
    Ann Pharmacother; 2007 May; 41(5):742-8. PubMed ID: 17440008
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical pharmacist in a multidisciplinary team in a paediatric department].
    Kjeldby C; Bjerre A; Refsum N
    Tidsskr Nor Laegeforen; 2009 Sep; 129(17):1746-9. PubMed ID: 19756055
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of pharmacist alternative therapy interventions in a pediatric Medicaid population.
    McNicol MC; Wheaton K; Abdel-Rasoul M; Monangai KE; Sebastian S
    J Manag Care Spec Pharm; 2023 Jul; 29(7):835-841. PubMed ID: 37404069
    [No Abstract]   [Full Text] [Related]  

  • 44. A computerized system to improve documentation and reporting of pharmacists' clinical interventions, cost savings, and workload activities.
    Zimmerman CR; Smolarek RT; Stevenson JG
    Pharmacotherapy; 1995; 15(2):220-7. PubMed ID: 7624270
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Implementing a comprehensive, 24-hour emergency department pharmacy program.
    Aldridge VE; Park HK; Bounthavong M; Morreale AP
    Am J Health Syst Pharm; 2009 Nov; 66(21):1943-7. PubMed ID: 19850790
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of oral chemotherapy pharmacists on cost avoidance of oral oncolytics in an integrated health system.
    Nguyen AL
    J Oncol Pharm Pract; 2023 Sep; 29(6):1369-1373. PubMed ID: 36002947
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proposed guidance on cost-avoidance studies in pharmacy practice.
    Patanwala AE; Narayan SW; Haas CE; Abraham I; Sanders A; Erstad BL
    Am J Health Syst Pharm; 2021 Aug; 78(17):1559-1567. PubMed ID: 34007979
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predicting the rate of physician-accepted interventions by hospital pharmacists in the United Kingdom.
    Barber ND; Batty R; Ridout DA
    Am J Health Syst Pharm; 1997 Feb; 54(4):397-405. PubMed ID: 9043562
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Postdischarge pharmacist medication reconciliation: impact on readmission rates and financial savings.
    Kilcup M; Schultz D; Carlson J; Wilson B
    J Am Pharm Assoc (2003); 2013; 53(1):78-84. PubMed ID: 23636160
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Collaborative practice agreement in solid organ transplantation.
    Ravichandran BR; Gillespie MW; Sparkes TM; Williams C; Bartlett ST; Haririan A; Masters BM
    Int J Clin Pharm; 2018 Apr; 40(2):474-479. PubMed ID: 29468527
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the contribution of clinical pharmacists: inpatient care and cost reduction.
    Hatoum HT; Hutchinson RA; Witte KW; Newby GP
    Drug Intell Clin Pharm; 1988 Mar; 22(3):252-9. PubMed ID: 3366065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).
    Houle SK; Chuck AW; McAlister FA; Tsuyuki RT
    Pharmacotherapy; 2012 Jun; 32(6):527-37. PubMed ID: 22552863
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Computer-based program for identifying medication orders requiring dosage modification based on renal function.
    Goldberg DE; Baardsgaard G; Johnson MT; Jolowsky CM; Shepherd M; Peterson CD
    Am J Hosp Pharm; 1991 Sep; 48(9):1965-9. PubMed ID: 1928142
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical and economic impact of pharmacists' intervention in a large volume chemotherapy preparation unit.
    Han JM; Ah YM; Suh SY; Jung SH; Hahn HJ; Im SA; Lee JY
    Int J Clin Pharm; 2016 Oct; 38(5):1124-32. PubMed ID: 27365091
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contributions of pharmacists through the promotion of proper drug use.
    Ise Y; Onda M; Miura Y; Shimazaki M; Kawada K; Hagiwara K; Katayama S; Kikuchi A; Kamei M; Kobayashi K; Shiragami M
    Yakugaku Zasshi; 2007 Jun; 127(6):1021-5. PubMed ID: 17541254
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical services provided by staff pharmacists in a community hospital.
    Garrelts JC; Smith DF
    Am J Hosp Pharm; 1990 Sep; 47(9):2011-5. PubMed ID: 2244945
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of pharmacists' clinical interventions on nonformulary drug use.
    Packer LA; Mahoney CD; Rich DS; Jeffrey LP
    Am J Hosp Pharm; 1986 Jun; 43(6):1461-6. PubMed ID: 3728481
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Documentation of pharmacist interventions in a decentralized unit dose system.
    Hoolihan RJ; Skoogman LH
    Hosp Pharm; 1991 Oct; 26(10):875-9. PubMed ID: 10114008
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Economic Outcomes Associated with a Pharmacist-Adjudicated Formulary Consult Service in a Veterans Affairs Medical Center.
    Britt RB; Hashem MG; Bryan WE; Kothapalli R; Brown JN
    J Manag Care Spec Pharm; 2016 Sep; 22(9):1051-61. PubMed ID: 27579827
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Physician assessment of pharmacists' interventions--a method of estimating cost avoidance and determining quality assurance.
    Bayliff CD; Einarson TR
    Can J Hosp Pharm; 1990 Aug; 43(4):167-71, 195. PubMed ID: 10105985
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.